Results 71 to 80 of about 56,983 (273)

Antifibrotic effects of specific targeting of the 5‐hydroxytryptamine 2B receptor (5‐HT2BR) in murine models and ex vivo models of scleroderma skin

open access: yesArthritis &Rheumatology, EarlyView.
Objective Systemic sclerosis (SSc) is a connective tissue disease with fibrotic remodeling of the skin and various internal organs. SSc is associated with the highest case‐specific mortality of all rheumatic autoimmune diseases with limited antifibrotic treatment options.
Thuong Trinh‐Minh   +12 more
wiley   +1 more source

SCLERODERMA AND SCLERODACTYLY [PDF]

open access: yesThe Journal of Nervous and Mental Disease, 1920
n ...
openaire   +4 more sources

The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma‐Associated Raynaud's Phenomenon: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

open access: yesArthritis & Rheumatology, 2017
To assess the therapeutic efficacy of local injections of botulinum toxin type A (Btx‐A) in improving blood flow to the hands of patients with Raynaud's phenomenon (RP) secondary to scleroderma.
Ricardo J. Bello   +9 more
semanticscholar   +1 more source

Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract The clinical and immunophenotypic attributes of reactive γδ T‐cell expansions are less well characterized than their malignant counterparts, which can pose diagnostic challenges. This study aims to investigate the characteristics and long‐term clinical outcomes of reactive γδ T‐cell expansions.
Hamza Tariq   +6 more
wiley   +1 more source

Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases

open access: yesFrontiers in Pharmacology, 2022
Background: In women with rheumatic diseases (RDs) menstruation-related disorders have never been investigated. The aim of this study was to evaluate gynecological symptoms/disorders in fertile age women with RDs.Materials and methods: All patients (n ...
Martina Orlandi   +10 more
doaj   +1 more source

Celiac disease screening in patients with scleroderma

open access: yesArquivos de Gastroenterologia, 2011
Both celiac disease and scleroderma have autoimmune etiology and affect the bowel causing diarrhea. As an association of autoimmune disease in a single individual is not rare, it is important to know if a patient with scleroderma may also have celiac ...
Renato Nisihara   +3 more
doaj   +1 more source

Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment

open access: yesJournal of Immunology Research, 2021
Background. Scleroderma is a complex disease involving autoimmune, vascular, and connective tissues, with unknown etiology that can progress through any organ systems. Objective.
Shirin Assar   +6 more
doaj   +1 more source

Prediction and forecasting models based on patient's history and biomarkers with application to Scleroderma disease [PDF]

open access: yesarXiv, 2018
This paper aims at predicting lung function values based on patients historical lung function values and serum biomarkers in Scleroderma patients. The progression of disease is measured by three lung function indexes (FVC, TLC, DLCO). Values of four biomarkers (TIMP1, P3NP, HA, NT-proBNP) are available.
arxiv  

Atypical hemolytic uremic syndrome: a rare complication of postendoscopic retrograde cholangiopancreatography pancreatitis

open access: yesJPGN Reports, EarlyView.
Abstract Endoscopic retrograde cholangiopancreatography (ERCP) is a crucial procedure for diagnosing and managing conditions affecting the pancreas and biliary tract. The procedure can be technically challenging and carries risks of complications, with post‐ERCP pancreatitis (PEP) being the most common.
Apoorva Nanagiri   +4 more
wiley   +1 more source

A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways

open access: yesFrontiers in Immunology
Systemic Sclerosis (SSc) is a systemic autoimmune disease of unknown etiology characterized by the development of frequently progressive cutaneous and internal organ fibrosis accompanied by severe vascular alterations.
Sergio A. Jimenez   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy